DNA repair mechanisms in cancer development and therapy

被引:262
作者
Torgovnick, Alessandro [1 ,2 ,3 ,4 ]
Schumacher, Bjoern [1 ,2 ,3 ,4 ]
机构
[1] Univ Cologne, Inst Genome Stabil Ageing & Dis, Fac Med, D-50931 Cologne, Germany
[2] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany
[3] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany
[4] Univ Cologne, Syst Biol Ageing Cologne, D-50931 Cologne, Germany
基金
欧洲研究理事会;
关键词
NUCLEOTIDE EXCISION-REPAIR; EMBRYONIC CELLULAR PROLIFERATION; FANCONI-ANEMIA PATHWAY; REPLICATION PROTEIN-A; MISMATCH-REPAIR; XERODERMA-PIGMENTOSUM; HOMOLOGOUS RECOMBINATION; MOLECULAR-MECHANISMS; DEFECTIVE REPAIR; DAMAGE RESPONSE;
D O I
10.3389/fgene.2015.00157
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
DNA damage has been long recognized as causal factor for cancer development. When erroneous DNA repair leads to mutations or chromosomal aberrations affecting oncogenes and tumor suppressor genes, cells undergo malignant transformation resulting in cancerous growth. Genetic defects can predispose to cancer: mutations in distinct DNA repair systems elevate the susceptibility to various cancer types. However, DNA damage not only comprises a root cause for cancer development but also continues to provide an important avenue for chemo- and radiotherapy. Since the beginning of cancer therapy, genotoxic agents that trigger DNA damage checkpoints have been applied to halt the growth and trigger the apoptotic demise of cancer cells. We provide an overview about the involvement of DNA repair systems in cancer prevention and the classes of genotoxins that are commonly used for the treatment of cancer. A better understanding of the roles and interactions of the highly complex DNA repair machineries will lead to important improvements in cancer therapy.
引用
收藏
页数:15
相关论文
共 171 条
  • [1] Human and bacterial oxidative demethylases repair alkylation damage in both RNA and DNA
    Aas, PA
    Otterlei, M
    Falnes, PO
    Vågbo, CB
    Skorpen, F
    Akbari, M
    Sundheim, O
    Bjorås, M
    Slupphaug, G
    Seeberg, E
    Krokan, HE
    [J]. NATURE, 2003, 421 (6925) : 859 - 863
  • [2] Preventing Nonhomologous End Joining Suppresses DNA Repair Defects of Fanconi Anemia
    Adamo, Adele
    Collis, Spencer J.
    Adelman, Carrie A.
    Silva, Nicola
    Horejsi, Zuzana
    Ward, Jordan D.
    Martinez-Perez, Enrique
    Boulton, Simon J.
    La Volpe, Adriana
    [J]. MOLECULAR CELL, 2010, 39 (01) : 25 - 35
  • [3] ALEXANIAN R, 1968, BLOOD, V31, P1
  • [4] Heavy charged particle radiobiology: Using enhanced biological effectiveness and improved beam focusing to advance cancer therapy
    Allen, Christopher
    Borak, Thomas B.
    Tsujii, Hirohiko
    Nickoloff, Jac A.
    [J]. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2011, 711 (1-2) : 150 - 157
  • [5] [Anonymous], 2011, RADIOBIOLOGY RADIOLO
  • [6] [Anonymous], 2001, The Metabolic and Molecular Basis of Inherited Disease
  • [7] Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells
    Arora, Sanjeevani
    Kothandapani, Anbarasi
    Tillison, Kristin
    Kalman-Maltese, Vivian
    Patrick, Steve M.
    [J]. DNA REPAIR, 2010, 9 (07) : 745 - 753
  • [8] DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
    Bakkenist, CJ
    Kastan, MB
    [J]. NATURE, 2003, 421 (6922) : 499 - 506
  • [9] Chk1 and Chk2 kinases in checkpoint control and cancer
    Bartek, J
    Lukas, J
    [J]. CANCER CELL, 2003, 3 (05) : 421 - 429
  • [10] Cancer and Radiation Therapy: Current Advances and Future Directions
    Baskar, Rajamanickam
    Lee, Kuo Ann
    Yeo, Richard
    Yeoh, Kheng-Wei
    [J]. INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2012, 9 (03): : 193 - 199